Blinatumomab as a Curative Therapy Option for Relapsed/Refractory Infant Acute Lymphoblastic Leukemia Post-Hematopoietic Stem Cell Transplantation - Case Report

• Main Authors: Suleimen Zhumatayev (Author), Koray Yalcin (Author), Safiye Suna Celen (Author), Vedat Uygun (Author), Gulsun Karasu (Author), Mehmet Akif Yesilipek (Author)
• Format: Book
• Published: The Korean Society of Pediatric Hematology-Oncology, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children, with a particularly poor prognosis in infants under one year of age. Hematopoietic stem cell transplantation (HSCT) is an effective therapy for relapsed or refractory ALL; however, relapse after HSCT remains a signific...